Rituximab on the Horizon - Hepatology clinical simulation case. The patient is sitting comfortably in the hepatology clinic. He was referred by the...
Age: 45 • Setting: Outpatient Consultation
Clinical Presentation & History
The patient is sitting comfortably in the hepatology clinic. He was referred by the oncology team before initiation of rituximab-based chemotherapy for newly diagnosed diffuse large B-cell lymphoma. He denies jaundice, abdominal pain, or constitutional symptoms.
Differential Diagnoses to Consider
Primary differential diagnoses evaluated in this clinical scenario:
Hepatitis B Virus Reactivation with Fulminant Hepatic Failure risk under Rituximab immunosuppression
Chemotherapy-Induced Direct Hepatotoxicity from R-CHOP regimen
Budd-Chiari Syndrome from Hypercoagulable Lymphoma State
Primary Hepatic Lymphoma Infiltration
High-Yield Clinical Pearls
Maintain a systematic approach from history taking to definitive intervention.
Diagnostic stewardship minimizes patient harm and diagnostic delay.
Diagnostic Pitfalls & Cognitive Error Warnings
Key reasoning traps and premature closure risks associated with this presentation:
Premature closure without complete investigation carries high diagnostic error risk.
Test Your Clinical Reasoning in Real Time
Step into the active clinician role for this case. Order diagnostic tests, analyze live laboratory panels, and navigate branching clinical decisions with real-time feedback.